MRP Capital Investments’s Labcorp LH Stock Holding History

MRP Capital Investments’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-134	Closed	-$27.1K	–	248
2022 Q4	$27.1K	Buy	+134	New	+$26.2K	0.03%	144

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

MRP Capital Investments's LH Position: Q1 2023 in Review

MRP Capital Investments sold out of Labcorp (LH) in Q1 2023, closing a stake of 134 shares — an estimated $27.1K sold.

MRP Capital Investments first reported a position in LH in Q4 2022 and held it in 1 quarter. The position peaked at $27.1K in Q4 2022. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

MRP Capital Investments reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
MRP Capital Investments sold 134 Labcorp shares in Q1 2023, an estimated $27.1K.
MRP Capital Investments first reported a position in Labcorp in Q4 2022 and held it in 1 quarter.
MRP Capital Investments's Labcorp position peaked at $27.1K in Q4 2022.
940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on MRP Capital Investments's 13F filing for Q1 2023, filed 12 May 2023.